The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder

Volume: 21, Issue: 10, Pages: 775 - 783
Published: Aug 3, 2018
Abstract
To create a gene expression signature (GES) to represent the biological effects of a combination of known drugs for bipolar disorder (BD) on cultured human neuronal cells (NT2-N) and rat brains, which also has evidence of differential expression in individuals with BD. To use the GES to identify new drugs for BD using Connectivity Map (CMap).Methods: NT2-N (n = 20) cells and rats (n = 8) were treated with a BD drug combination (lithium,...
Paper Details
Title
The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
Published Date
Aug 3, 2018
Volume
21
Issue
10
Pages
775 - 783
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.